West Pharmaceutical Services designs and manufactures containment and delivery components for injectable drugs, including elastomeric stoppers, seals, syringe systems and related packaging. Pharma and biotech firms use its products to keep sterile drugs stable from filling through patient administration. The business is known for high regulatory and quality barriers and deep integration into customers’ fill-finish lines. It sits at a critical point in the injectable-drug supply chain rather than selling finished medicines.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 766.5 | — | 131.8 | 19% |
| Q3 2025 | 804.6 | — | 140 | 0.7% |
| Q4 2025 | 805 | — | 132.1 | 0.2% |
| Q1 2026 | 844.9 | — | 138.8 | 31.9% |
| Q2 2026 | 872.3 | 13.8% | 154 | 16.8% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Nomura Holdings, Inc. (NMR), DTE Energy Company (DTE), American Water Works Company, Inc. (AWK), FirstEnergy Corp. (FE), CenterPoint Energy, Inc. (CNP), Citizens Financial Group, Inc. (CFG)